Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3008235829.
Violations0
Issue DateJul 1, 2024
Product TypeDrugs
StatusOpen
Letter Details
Firm
Genuine Virgin Aloe Corp dba Triderma
Location
United States
FEI Number
3008235829
Country
United States
Issue Date
July 01, 2024
Issuing Office
Division of Pharmaceutical Quality Operations IV
Product Type
Drugs
Status
Open
Summary
Genuine Virgin Aloe Corp, operating as Triderma, received an FDA Warning Letter on July 1, 2024 regarding drug products. Based on the limited metadata available, specific violation details cannot be determined as the full letter content is not accessible. The warning falls under FDA drug regulatory authority, though the specific manufacturing, marketing, or compliance issues cannot be detailed without the complete correspondence.
Genuine Virgin Aloe Corp dba Triderma FDA Warning Letter, July 1, 2024
Talk to a Specialist